Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy
Launched by CAIRO UNIVERSITY · Oct 25, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how focused extracorporeal shock wave therapy affects nerve and muscle function in patients with cervical radiculopathy, a condition that causes pain and weakness in the arms due to issues in the neck. The study aims to see if this treatment can help reduce pain and improve function in people who have specific types of nerve problems, confirmed by MRI scans.
To be eligible for the trial, participants should be between 36 and 46 years old, have been experiencing pain for more than three months, and have a confirmed diagnosis of unilateral disc-related cervical radiculopathy affecting the lower neck. They should also have noticeable differences in nerve function on each side of their body. However, those with certain conditions, like severe arthritis or spinal issues, won't be able to participate. If you join the study, you can expect to receive the shock wave therapy and take part in assessments to see how well it works for you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All patients suffer from unilateral discogenic cervical radiculopathy of lower cervical spine(C5-C6 and/ or C6-C7) as confirmed with MRI.
- • 2. All patients suffer from pain and tenderness on active trigger points of the upper trapezius .
- • 3. Age ranging from 36 to 46 years old.
- • 4. Duration of symptoms more than 3 months to avoid acute stage of inflammation.
- • 5. Side to side amplitude differences of 50% or more in DSSEPs measurement (Naguszewski et al.,2001)
- Exclusion Criteria:
- • 1. Posterior osteophytes
- • 2. Spinal canal stenosis
- • 3. Rheumatoid arthritis
- • 4. Vestibular insufficiency
- • 5. Osteoporosis
- • 6. Any signs or symptoms of myelopathy
- • 7. Any abnormalities of deep sensation
- • 8. Associated pathologies of upper cervical region or the upper limb that may cause overlapping with clinical findings as referred pain from costotransverse joint, rotator cuff tendonitis, cervical rib syndrome and entrapment neuropathy.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Dokki, Egypt
Giza, Ad Doqi, Giza District, Giza Governorate, Egypt
Patients applied
Trial Officials
Engy BadrEldin S Moustafa, PhD
Principal Investigator
Faculty of Physical Therapy, Cairo University, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported